251 related articles for article (PubMed ID: 24290398)
21. Magnesium sulfate for neuroprotection in patients at risk for early preterm delivery: not yet.
Sibai BM
Am J Obstet Gynecol; 2011 Oct; 205(4):296-7. PubMed ID: 22083053
[No Abstract] [Full Text] [Related]
22. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.
Rouse DJ; Hirtz DG; Thom E; Varner MW; Spong CY; Mercer BM; Iams JD; Wapner RJ; Sorokin Y; Alexander JM; Harper M; Thorp JM; Ramin SM; Malone FD; Carpenter M; Miodovnik M; Moawad A; O'Sullivan MJ; Peaceman AM; Hankins GD; Langer O; Caritis SN; Roberts JM;
N Engl J Med; 2008 Aug; 359(9):895-905. PubMed ID: 18753646
[TBL] [Abstract][Full Text] [Related]
23. More on prenatal magnesium sulfate and risk of cerebral palsy.
Nelson KB; Grether JK
JAMA; 1997 Nov; 278(18):1493. PubMed ID: 9363965
[No Abstract] [Full Text] [Related]
24. School-age outcomes following a randomized controlled trial of magnesium sulfate for neuroprotection of preterm infants.
Chollat C; Enser M; Houivet E; Provost D; Bénichou J; Marpeau L; Marret S
J Pediatr; 2014 Aug; 165(2):398-400.e3. PubMed ID: 24837863
[TBL] [Abstract][Full Text] [Related]
25. [Use of magnesium sulfate in obstetrics].
Kayem G; Mandelbrot L; Haddad B
Gynecol Obstet Fertil; 2012 Oct; 40(10):605-13. PubMed ID: 22995056
[TBL] [Abstract][Full Text] [Related]
26. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis.
Conde-Agudelo A; Romero R
Am J Obstet Gynecol; 2009 Jun; 200(6):595-609. PubMed ID: 19482113
[TBL] [Abstract][Full Text] [Related]
27. Magnesium sulphate for fetal neuroprotection.
Costa Fda S; Lopes L; Brennecke S
Rev Bras Ginecol Obstet; 2011 Jun; 33(6):265-70. PubMed ID: 21877014
[No Abstract] [Full Text] [Related]
28. What we learned about the role of antenatal magnesium sulfate for the prevention of cerebral palsy.
Rouse DJ; Hirtz D;
Semin Perinatol; 2016 Aug; 40(5):303-6. PubMed ID: 27117179
[TBL] [Abstract][Full Text] [Related]
29. Magnesium sulfate and cerebral palsy in premature infants.
Hirtz DG; Nelson K
Curr Opin Pediatr; 1998 Apr; 10(2):131-7. PubMed ID: 9608889
[TBL] [Abstract][Full Text] [Related]
30. [Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial].
Marret S; Marpeau L; Follet-Bouhamed C; Cambonie G; Astruc D; Delaporte B; Bruel H; Guillois B; Pinquier D; Zupan-Simunek V; Bénichou J;
Gynecol Obstet Fertil; 2008 Mar; 36(3):278-88. PubMed ID: 18337147
[TBL] [Abstract][Full Text] [Related]
31. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis.
Costantine MM; Weiner SJ;
Obstet Gynecol; 2009 Aug; 114(2 Pt 1):354-364. PubMed ID: 19622997
[TBL] [Abstract][Full Text] [Related]
32. Working to improve survival and health for babies born very preterm: the WISH project protocol.
Crowther CA; Middleton PF; Bain E; Ashwood P; Bubner T; Flenady V; Morris J; McIntyre S;
BMC Pregnancy Childbirth; 2013 Dec; 13():239. PubMed ID: 24354790
[TBL] [Abstract][Full Text] [Related]
33. [Neuroprotection for preterm infants with antenatal magnesium sulphate].
Marret S; Ancel PY
J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1418-1433. PubMed ID: 28166926
[TBL] [Abstract][Full Text] [Related]
34. Magnesium for neuroprophylaxis: fact or fiction?
Cahill AG; Caughey AB
Am J Obstet Gynecol; 2009 Jun; 200(6):590-4. PubMed ID: 19482112
[TBL] [Abstract][Full Text] [Related]
35. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia.
Grether JK; Hoogstrate J; Walsh-Greene E; Nelson KB
Am J Obstet Gynecol; 2000 Sep; 183(3):717-25. PubMed ID: 10992199
[TBL] [Abstract][Full Text] [Related]
36. Magnesium sulfate for preterm neuroprotection.
Mittendorf R; Lee KS; Roizen NJ; Pryde PG
JAMA; 2004 Feb; 291(8):940-1; author reply 941. PubMed ID: 14982906
[No Abstract] [Full Text] [Related]
37. Magnesium sulphate for fetal neuroprotection at imminent risk for preterm delivery: a systematic review with meta-analysis and trial sequential analysis.
Wolf HT; Huusom LD; Henriksen TB; Hegaard HK; Brok J; Pinborg A
BJOG; 2020 Sep; 127(10):1180-1188. PubMed ID: 32237069
[TBL] [Abstract][Full Text] [Related]
38. Cerebral palsy in very low birth weight infants, pre-eclampsia and magnesium sulphate.
Blair E; Palmer L; Stanley F
Pediatrics; 1996 May; 97(5):780-2. PubMed ID: 8628635
[No Abstract] [Full Text] [Related]
39. Evaluation of the clinical use of magnesium sulfate for cerebral palsy prevention.
Gibbins KJ; Browning KR; Lopes VV; Anderson BL; Rouse DJ
Obstet Gynecol; 2013 Feb; 121(2 Pt 1):235-240. PubMed ID: 23344271
[TBL] [Abstract][Full Text] [Related]
40. Fetal pharmacotherapy 3: magnesium sulfate.
Namouz-Haddad S; Koren G
J Obstet Gynaecol Can; 2013 Dec; 35(12):1101-1104. PubMed ID: 24405877
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
